Literature DB >> 30184781

Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia.

Relton Romeis Oliveira1, Marcus S Carrião2, Maiulle Teixeira Pacheco1, Luis Cesar Branquinho2, Ana Luiza R de Souza1, Andris F Bakuzis2, Eliana M Lima3.   

Abstract

We developed a magnetic solid lipid nanoparticles formulation of paclitaxel (PTX-loaded MSLNs) via emulsification-diffusion method. The physicochemical characterization of PTX-loaded MSLNs was performed by AFM, DLS, determination of entrapment efficiency (EE) and drug loading (DL), DSC, VSM, and physical stability. The in vitro effect of temperature and pulsed magnetic hyperthermia on drug release were studied. PTX-loaded MSLNs had a particle diameter around 250 nm with a narrow size distribution, spherical morphology, EE of 67.3 ± 1.2% and a DL of 17.1 ± 0.4 μg/mg. A decrease of the melting point of the lipid was observed following the preparation of the MSLNs. A threefold increase in the in vitro drug release rate was seen when temperature was raised from 25 to 43 °C. The lipid coating of MPs confer a temperature-dependent drug release and magnetic hyperthermia was used to trigger controlled PTX release from MSLNs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Magnetic hyperthermia; Magnetic solid lipid nanoparticles; Paclitaxel; Thermoresponsive nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 30184781     DOI: 10.1016/j.msec.2018.07.011

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

1.  What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

Authors:  Carlotta Pucci; Chiara Martinelli; Gianni Ciofani
Journal:  Future Oncol       Date:  2019-12-24       Impact factor: 3.404

2.  Biocompatible Magnetic Colloidal Suspension Used as a Tool for Localized Hyperthermia in Human Breast Adenocarcinoma Cells: Physicochemical Analysis and Complex In Vitro Biological Profile.

Authors:  Elena-Alina Moacă; Claudia-Geanina Watz; Vlad Socoliuc; Roxana Racoviceanu; Cornelia Păcurariu; Robert Ianoş; Simona Cîntă-Pînzaru; Lucian Barbu Tudoran; Fran Nekvapil; Stela Iurciuc; Codruța Șoica; Cristina-Adriana Dehelean
Journal:  Nanomaterials (Basel)       Date:  2021-04-30       Impact factor: 5.076

3.  Folate-Targeted PEGylated Magnetoliposomes for Hyperthermia-Mediated Controlled Release of Doxorubicin.

Authors:  Emílio R Cintra; Tacio G Hayasaki; Ailton A Sousa-Junior; Artur C G Silva; Marize C Valadares; Andris F Bakuzis; Sebastião A Mendanha; Eliana M Lima
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

Review 4.  Recent advances of drug delivery nanocarriers in osteosarcoma treatment.

Authors:  Shang-Yu Wang; Hong-Zhi Hu; Xiang-Cheng Qing; Zhi-Cai Zhang; Zeng-Wu Shao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

Review 5.  Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics.

Authors:  Mónica Cerqueira; Efres Belmonte-Reche; Juan Gallo; Fátima Baltazar; Manuel Bañobre-López
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.